Tenet Healthcare valuation

THC · NYSE · USD

$261.43Change from previous close: +1.15%Absolute change: +$2.96

Close · October 7, 2026

Valuation

The P/E ratio is 10.0. The average price target of 22 analysts is $284.64.

Data as of October 7, 2026

Valuation multiples

Market cap
$20.81B
Enterprise value
$35.93B
P/E (trailing 12 months)
10.0
Forward P/E
12.3
PEG
1.80
Price/book
4.47
Price/sales
0.95
EV/EBITDA
7.42
EV/revenue
1.65

Profitability and growth

Gross margin
41.7%
Operating margin
18.2%
Net margin
10.3%
ROE
37.3%
ROA
8.3%
ROIC
16.7%
Revenue growth (year over year)
6.8%
Earnings growth (year over year)
213.4%

Financial health

Total cash
$2.17B
Total debt
$13.25B
Debt/equity
1.52
Current ratio
1.41
Quick ratio
1.15
Altman Z-Score
1.96
Piotroski F-Score
7.00

Dividends

Payout ratio
0.0%
Ex-dividend date
March 13, 2000

Analysts and estimates

Average price target
$284.64
Median price target
$284.00
High price target
$315.00
Low price target
$260.00
Analysts with a price target
22
Consensus
Buy
Forward EPS
$21.08
EPS estimate, current year
$21.22

Shares and trading

Beta
1.20
Average volume
974.83K
Shares outstanding
80.52M
Float
79.68M
Institutional ownership
102.0%
Insider ownership
1.0%
Short interest (% of float)
2.9%
Short ratio (days)
2.75